P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MUL...

por Mele, G, Cascavilla, N, Di Renzo, N, Guarini, A, Mazza, P, Melillo, L, Pavone, V, Tarantini, G, Curci, P, Falcone, AP, Germano, C, Mele, A, Palazzo, G, Palumbo, G, Reddiconto, G, Rossini, B, Specchia, G, Musto, P, Pastore, D
Publicado 2022

P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN M...

por Mele, G, Cascavilla, N, Di Renzo, N, Guarini, A, Mazza, P, Melillo, L, Pavone, V, Tarantini, G, Curci, P, Falcone, AP, Germano, C, Mele, A, Palazzo, G, Palumbo, G, Reddiconto, G, Rossini, B, Specchia, G, Musto, P, Pastore, D
Publicado 2022

PB2016: COMPARISON BETWEEN DRD VS KRD AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS IN FIRST RELAPSE: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP)

por Mele, A., Prete, E., Citiso, S., Mele, G., Pastore, D., Sgherza, N., Curci, P., Musto, P., Falcone, A. P., Cascavilla, N., Germano, C., Giuseppe, T., Reddiconto, G., Di Renzo, N., Palazzo, G., Mazza, P., Rossini, B., Guarini, A., Palumbo, G., Melillo, L. M. A., Pavone, V.
Publicado 2022

P1084: CHECK-POINT INHIBITORS IN PATIENTS WITH RELAPSE/REFRACTORY HODGKIN’S LYMPHOMA: A RETROSPECTIVE ANALYSYS BY THE RETE EMATOLOGICA PUGLIESE (REP).

por Gaudio, F., Loseto, G., Bozzoli, V., Scalzulli, P. R., Mazzone, A. M., Tonialini, L., Fesce, V., Quintana, G., De santis, G., Masciopinto, P., Arcuti, E., Clemente, F., Scardino, S., Tarantini, G., Pastore, D., Melillo, L., Pavone, V., Mazza, P., Carella, A. M., Cascavilla, N., Di Renzo, N., Guarini, A., Musto, P.
Publicado 2022